David J. Cohen
David J. Cohen
Director of Clinical and Outcomes Research, Cardiovascular Research Foundation
Verified email at
Cited by
Cited by
Clinical end points in coronary stent trials: a case for standardized definitions
DE Cutlip, S Windecker, R Mehran, A Boam, DJ Cohen, GA van Es, ...
Circulation 115 (17), 2344-2351, 2007
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
JL Saver, M Goyal, A Bonafe, HC Diener, EI Levy, VM Pereira, GW Albers, ...
New England Journal of Medicine 372 (24), 2285-2295, 2015
Transcatheter or surgical aortic-valve replacement in intermediate-risk patients
MB Leon, CR Smith, MJ Mack, RR Makkar, LG Svensson, SK Kodali, ...
New England Journal of Medicine 374 (17), 1609-1620, 2016
Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients
MJ Mack, MB Leon, VH Thourani, R Makkar, SK Kodali, M Russo, ...
New England Journal of Medicine 380 (18), 1695-1705, 2019
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
AP Kappetein, SJ Head, P Généreux, N Piazza, NM Van Mieghem, ...
Journal of the American College of Cardiology 60 (15), 1438-1454, 2012
Stenting versus endarterectomy for treatment of carotid-artery stenosis
TG Brott, RW Hobson, G Howard, GS Roubin, WM Clark, W Brooks, ...
New England Journal of Medicine 363 (1), 11-23, 2010
Transcatheter mitral-valve repair in patients with heart failure
GW Stone, JA Lindenfeld, WT Abraham, S Kar, DS Lim, JM Mishell, ...
New England Journal of Medicine 379 (24), 2307-2318, 2018
Strategies for multivessel revascularization in patients with diabetes
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ...
New England journal of medicine 367 (25), 2375-2384, 2012
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp, DE Cutlip, PG Steg, ...
New England Journal of Medicine 371 (23), 2155-2166, 2014
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 …
AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman, JD Jackman, ...
Jama 289 (7), 853-863, 2003
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials
DE Cutlip, DS Baim, KKL Ho, JJ Popma, AJ Lansky, DJ Cohen, ...
Circulation 103 (15), 1967-1971, 2001
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
VH Thourani, S Kodali, RR Makkar, HC Herrmann, M Williams, ...
The Lancet 387 (10034), 2218-2225, 2016
Stenting and medical therapy for atherosclerotic renal-artery stenosis
CJ Cooper, TP Murphy, DE Cutlip, K Jamerson, W Henrich, DM Reid, ...
New England Journal of Medicine 370 (1), 13-22, 2014
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry
JA Spertus, R Kettelkamp, C Vance, C Decker, PG Jones, JS Rumsfeld, ...
Circulation 113 (24), 2803-2809, 2006
Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention
RW Yeh, EA Secemsky, DJ Kereiakes, SLT Normand, AH Gershlick, ...
Jama 315 (16), 1735-1749, 2016
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
EJ Topol, DJ Moliterno, HC Herrmann, ER Powers, CL Grines, DJ Cohen, ...
New England Journal of Medicine 344 (25), 1888-1894, 2001
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
AP Kappetein, SJ Head, P Généreux, N Piazza, NM Van Mieghem, ...
The Journal of thoracic and cardiovascular surgery 145 (1), 6-23, 2013
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
DS Pinto, AJ Kirtane, BK Nallamothu, SA Murphy, DJ Cohen, RJ Laham, ...
Circulation 114 (19), 2019-2025, 2006
Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison
CJ Cooper, RA El-Shiekh, DJ Cohen, L Blaesing, MW Burket, A Basu, ...
American heart journal 138 (3), 430-436, 1999
Incidence and treatment of'no-reflow'after percutaneous coronary intervention.
RN Piana, GY Paik, M Moscucci, DJ Cohen, CM Gibson, AD Kugelmass, ...
circulation 89 (6), 2514-2518, 1994
The system can't perform the operation now. Try again later.
Articles 1–20